Medical Marijuana

PUBLIC STRATEGIES, LLC

www.publicstrategiesllc.net

FOR IMMEDIATE RELEASE           

JUNE 29, 2010

Montel Williams to NY Legislators: Pass Medical Marijuana Now

Former Talk Show Host, MS Patient Urges Albany Lawmakers to Act Without Delay

CONTACT: Vince Marrone ……… 914-912-0526 or [email protected]

ALBANY, NEW YORK — At a press conference in Albany on Tuesday, former talk show host, U.S. Navy officer and New York City resident Montel Williams urged New York Governor David Paterson and members of the Legislature to act quickly in order to pass New York’s medical marijuana bill. 

            The New York bill would create one of the best-regulated systems in the country for providing seriously ill patients with safe and effective access to medical marijuana. Mr. Williams suffers from multiple sclerosis, and uses medical marijuana to help ease the effects of his condition.

            “New York needs to act now to make marijuana legally available for medical use. Every day that we delay is another day of needless suffering for patients like me all across the state,” Williams said.

            “Thousands of New Yorkers suffer from serious medical conditions that could benefit from the medical use of marijuana,” said Assembly Member Richard N. Gottfried, Chair of the Assembly Health Committee and sponsor of the Assembly medical marijuana bill. “If the patient and the doctor agree that the most effective medicine is marijuana, the government should not stand in the way.  It is cruel to turn suffering patients into criminals when they are following what their doctor recommends.”

            “Medical use of marijuana for patients with acute conditions like HIV/AIDS, cancer, multiple sclerosis, and glaucoma relieves chronic pain and nausea and increases appetite,” said Sen. Eric Adams (D-Brooklyn), a former New York City police captain. “When our fellow humans are burdened by the dire effects of life-threatening illnesses, we must not allow insubstantial ideological arguments to increase their suffering. The proposed medical marijuana legislation contains the critical safeguards needed to guard against diversion or abuse and establish access for patients in need.  It is our moral and ethical duty to alleviate misery in our fellow human beings. Any other substance shown to have such beneficial effect would already be in the arsenal of medical practitioners. I wholeheartedly urge passage of this legislation.”

            Also joining Mr. Williams was Craig Burridge, executive director of the Pharmacists Society of the State of New York (PSSNY). PSSNY recently came out in support of New York’s medical marijuana bill.

            “New York has the opportunity to provide a model on how to mainstream medical marijuana to those patients who so desperately need it,” Burridge said. “For those of us who have seen the suffering of a loved one, passage is long overdue.”

The New York bill would:

 * Allow patients facing serious, life-threatening or debilitating illnesses to get marijuana upon the recommendation of their physician.

 * Limit patient possession to no more than 2.5 ounces.

 * Grant the Department of Health the authority to license medical marijuana producers and dispensers, consistent with rules mirroring the state Controlled Substances Act.

 * Allow the Department of Health to establish fees sufficient to cover the cost of administering the program.

 * Allow state-licensed organizations, including pharmacies, to dispense medical marijuana to qualified patients.

 * Allow state-licensed organizations to produce marijuana for sale to dispensers only.

            Since 1996, 14 states and the District of Columbia have passed medical marijuana laws. More than a dozen state legislatures considered the issue this year, and in November, citizens of Arizona and South Dakota will vote on medical marijuana ballot initiatives. Under New York’s bill, the state department of health would play an active role in regulating pharmacies and dispensaries that would be licensed to provide medical marijuana to qualified patients.

####

FOR IMMEDIATE RELEASE                                                                                                                                 

JULY 21, 2010

Following Recent Raids, Medical Marijuana Advocacy Groups Call on Pres. Obama to Withdraw Nomination of Michele Leonhart to be DEA Administrator

Obama’s DEA Head Must Follow Stated Medical Marijuana Policy, End Obstruction of Marijuana Research, and Base Marijuana Rescheduling on Science Rather Than Ideology

CONTACT: Steve Fox: 202-905-2042 or [email protected]; or Mike Meno: 202-905-2030 or [email protected]

WASHINGTON, D.C. — Today, a coalition of organizations supportive of medical marijuana patients and providers (see list of organizations below) is calling on President Obama to withdraw his nomination of Michele Leonhart to serve as administrator of the Drug Enforcement Administration (DEA). Ms. Leonhart, who is currently the DEA’s acting-administrator, has not demonstrated that she is capable of leading the agency in a thoughtful manner at a time when 14 states have enacted medical marijuana laws and science is increasingly confirming the therapeutic benefits of the substance.

            Under Leonhart's leadership, the DEA has staged medical marijuana raids in apparent disregard of Attorney General Eric Holder's directive to respect state medical marijuana laws. Most recently, DEA agents flouted a pioneering Mendocino County (CA) ordinance to regulate medical marijuana cultivation by raiding the very first grower to register with the sheriff. Joy Greenfield, 69, had paid more than $1,000 for a permit to cultivate 99 plants in a collective garden that had been inspected and approved by the local sheriff.

            Informed that Ms. Greenfield had the support of the sheriff, the DEA agent in charge responded by saying, “I don’t care what the sheriff says.” The DEA's conduct is inconsistent with an October 2009 Department of Justice memo directing officials not to arrest individuals “whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.”

            Ms. Leonhart has also demonstrated that she is unable to be objective in carrying out the duties of the administrator as it relates to medical marijuana research. In January 2009, she refused to issue a license to the University of Massachusetts to cultivate marijuana for FDA-approved research, despite a DEA administrative law judge’s ruling that it would be “in the public interest” to issue the license. This single act has blocked privately funded medical marijuana research in this country. The next DEA administrator will likely influence the outcome of a marijuana-rescheduling petition currently before the agency. It is critical that an administrator with an open mind toward science and research is at the helm.

            “With Leonhart’s nomination pending, one would expect her to be more — not less — respectful of the Department of Justice and the rights of individuals in medical marijuana states,” said Steve Fox, director of government relations at the Marijuana Policy Project. “Such behavior is an ominous sign for the future of the DEA under her leadership. Moreover, she has continually demonstrated her desire to block privately funded medical marijuana research in this country. The Obama administration has reversed many Bush administration policies over the past 18 months. It is time to transform the culture at the DEA by either withdrawing Leonhart’s nomination or directing her to change her attitude toward medical marijuana.”

#   #   #   #   #

The following organizations are calling on President Obama to withdraw the nomination of Ms. Leonhart if she does not end the attacks on individuals acting in compliance with state medical marijuana laws and commit to making decisions related to medical marijuana based on science, not a personal anti-marijuana bias:

 

California NORML

Drug Policy Alliance (DPA)

Law Enforcement Against Prohibition (LEAP)

Marijuana Policy Project (MPP)

National Organization for the Reform of Marijuana Laws (NORML)

Students for Sensible Drug Policy (SSDP)

 

With more than 124,000 members and supporters nationwide, the Marijuana Policy Project is the largest marijuana policy reform organization in the United States. For more information, please visit www.mpp.org.

####

FOR IMMEDIATE RELEASE
The Coalition for Medical Marijuana New Jersey (CMMNJ)
www.cmmnj.org

CONTACT: Ken Wolski RN 609 391 2137 [email protected] or Chris Goldstein [email protected]

Plan for medical marijuana at hospitals called "pie in the sky"

Last month the New Jersey Legislature delayed medical marijuana access and floated a new concept for the program: Rutgers University could be named as the sole source for all medical cannabis cultivation and the marijuana would be distributed only by hospitals.

The full presentation from the New Jersey Council of Teaching Hospitals (NJCTH) was reported in the Newark Star-Ledger today.  CMMNJ’s Chris Goldstein spoke via phone Friday with NJCTH President J. Richard Goldstein (no relation). He said that NJCTH was invited for what were described as informational discussions in Trenton and not to draft language for the law, calling the medical marijuana proposal “pie in the sky.” 
NJCTH’s Goldstein explained, “This is not a full plan. This was just an initial conversation with some key players. The Christie Administration just ran with it.”

Governor Chris Christie’s staff and some legislators have been speaking frequently with the media about the proposals. Patients could access marijuana at hospitals, to be sure, and Rutgers University certainly has the capability of farming medical cannabis. But their Boards of Directors and retained attorneys would be hard pressed to take on the one thing that private businesses already do: Risk.

New Jersey hospitals and Rutgers University have not fully examined their federal liabilities.  None of those entities have committed themselves to putting their assets on the line for sick and dying patients. They are not alone; not a single hospital or university in the US currently engages in the production or distribution of state regulated medical marijuana.*  Thirteen states have medical marijuana programs running where private non-profit or for-profit business owners take on the tremendous risk presented by ongoing federal prohibition. Any one of several authorities could seize their properties and assets at any given moment. The owners and employees of medical cannabis businesses also take on the risk of personally losing their freedom through federal arrest.

There do exist groups of private citizens ready to get New Jersey ’s program running.  New Jersey’s medical cannabis patient advocacy groups and others groups interested in offering information about the medical marijuana program have not been afforded the same opportunities to meet with “key players” that Rutgers the NJCTH have enjoyed.  Form letters sent from the New Jersey Department of Health and Senior Services claimed that state officials were considering no proposals from any group.

The New Jersey Compassionate Use Medical Marijuana Act currently calls for the initial licensing of six, private Alternative Treatment Centers (ATCs) around the state.  Patients can only gain legal protections by purchasing marijuana from an authorized ATC.  The NJ Department of Health and Senior Services is currently scheduled to begin the regulatory process in October and bring the medical cannabis program online starting in January 2011.
 
The Coalition for Medical Marijuana New Jersey is intensifying efforts to educate the public and legislators about the ways to best serve the patients who qualify under the law.  Ken Wolski RN, executive director of CMMNJ, said, "The proposal to monopolize New Jersey's medical marijuana program to provide a funding source for training new doctors in the state represents a betrayal of the very patients that the law was designed to protect and serve."

A cannabinoid researcher from Temple University will address the CMMNJ monthly public meeting which will be held on July 13, 2010 at the Lawrence Township (Mercer Co.) Public Library from 7 - 9 pm.

* The University of Mississippi hosts the only DEA licensed marijuana cultivation facility. The single strain of cannabis is distributed to four federal medical marijuana patients. The National Institute on Drug Abuse (NIDA) also oversees the federal marijuana. It is used for research on a very limited basis.

 

Ken Wolski, RN, MPA
Executive Director
Coalition for Medical Marijuana--New Jersey, Inc.  www.cmmnj.org
219 Woodside Ave.
Trenton, NJ 08618
609.394.2137
[email protected]

CONTACT: Ken Wolski RN 609 391 2137 [email protected] or Chris Goldstein [email protected]

 

nonprofit software